Jasper Therapeutics
JSPR
JSPR
61 hedge funds and large institutions have $380M invested in Jasper Therapeutics in 2024 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 20 increasing their positions, 8 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
100% more funds holding in top 10
Funds holding in top 10: 3 → 6 (+3)
79.6% more ownership
Funds ownership: 6.92% → 86.51% (+80%)
49% more funds holding
Funds holding: 41 → 61 (+20)
Holders
61
Holding in Top 10
6
Calls
$4.27M
Puts
$855K
Top Buyers
| 1 | +$13.5M | |
| 2 | +$12.8M | |
| 3 | +$9.33M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$7.71M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$7.24M |
Top Sellers
| 1 | -$2.9M | |
| 2 | -$1.76M | |
| 3 | -$1.35M | |
| 4 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
-$1.2M |
| 5 |
SVCM
Saturn V Capital Management
Austin,
Texas
|
-$1.09M |